- WHATS NEW?
- Suppression of chemokines by HDL
- HDL cholesterol linked to oestrogen levels
- New gene loci regulating HDL cholesterol identified
- Abnormal lipids when young predicts atherosclerosis in later life
- JUPITER: Is HDL cholesterol relevant to residual risk in low-risk patients on potent statin therapy?
- EAS Workshop: How does HDL protect against atherosclerosis?
Dalcetrapib: 48 week trial
Longer-term lipid-modifying efficacy with dalcetrapib with no evidence of clinically relevant changes in blood pressure or aldosterone or incraese in adverse events.
Corporate sponsor
